跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TMP
首页
药物
TMP
Experimental
Small Molecule
TMP
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
10
H
15
N
2
O
9
P
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Devices and methods for integrated continuous manufacturing of biological molecules
US 9045725 B2
申请人: VOGEL JENS HOLGER
优先权: 2005
CN
US
6 件公开
TERAMEPROCOL AND NORDIHYDROGUAIARETIC ACID (NDGA) DERIVATIVES AS CORONAVIRUS ANTI-VIRAL AGENTS
EP 4280875 A4
申请人: ERIMOS PHARMACEUTICALS LLC
优先权: 2021
CN
EP
US
WO
5 件公开
MODIFIED ANTI-INFLAMMATORY PROTEINS AND METHOD OF USE
EP 4509188 A3
申请人: UNIV JAMES COOK
优先权: 2013
CN
EP
US
5 件公开
MANUFACTURING 2,3,5-TRIMETHYLHYDROQUINONE FROM A MIXTURE OF MESITOL AND 2,3,6-TRIMETHYLPHENOL
EP 4673421 A1
申请人: DSM IP ASSETS BV
优先权: 2023
CN
EP
US
WO
4 件公开
Small molecules for dual function positron emission tomography (PET) and cell suicide switches
US 11253616 B2
申请人: UNIV PENNSYLVANIA
优先权: 2018
US
4 件公开
T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF
EP 4780842 A1
申请人: CUE BIOPHARMA INC
优先权: 2023
EP
US
WO
3 件公开
US 20250120996 A1
申请人: CUE BIOPHARMA INC
优先权: 2019
CN
US
2 件公开
US 20260176379 A1
申请人: CUE BIOPHARMA INC
优先权: 2023
US
WO
2 件公开
US 20260109958 A1
申请人: CUE BIOPHARMA INC
优先权: 2023
US
WO
2 件公开
Method for treating inflammation with an Ac-TMP-2 protein
US 9637527 B2
申请人: UNIV JAMES COOK
优先权: 2012
CN
US
3 件公开
Bioorthogonal chemical inducers of reversible dimerization for control of protein interactions in cells
EP 2667196 A1
申请人: MAX PLANCK GESELLSCHAFT
优先权: 2012
EP
US
2 件公开
Method for synthesizing sodium 2,2,6,6-tetramethylpiperidides
US 10836723 B2
申请人: KOBELCO ECO SOLUTIONS CO LTD
优先权: 2017
CN
US
2 件公开
Methods for Treating HPV16-Associated Cancers
US 20260240979 A1
申请人: CUE BIOPHARMA INC
优先权: 2023
US
WO
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈